22nd Jan 2024 Two different concentrations of GP2017 (a biosimilar medicine) are associated with similar drug levels in the body- a plain language summary
29th Sep 2023 A plain language summary of the PATHWAY and NAVIGATOR studies: tezepelumab for the treatment of severe asthma
2nd Jun 2023 Plain Language Summary: comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms